期刊文献+

5-Fu持续静脉滴注治疗转移性结直肠癌的临床研究 被引量:1

Clinical Research of Continuous Venous Infusion of Low-Dose 5-Fluorouracil in the Treatment of Metastasis Colorectal Cancer
下载PDF
导出
摘要 目的观察低剂量5-氟尿嘧啶(5-FU)持续静脉滴注治疗常规含5-FU类方案失败的进展期结直肠癌的近期疗效和毒副反应。方法 17例经传统的一、二线方案化疗失败的进展期结直肠癌患者,给予5-FU 200 mg/m2/d微量泵持续静脉滴注,治疗至疾病进展。结果全组17例均可评价,其中完全缓解(CR)0例,部分缓解(PR)2例,稳定(SD)7例,进展(PD)8例,有效率(RR)11.7%,临床获益率(CR+PR+SD)52.8%。毒副反应主要是I~Ⅱ级口腔黏膜炎和手足综合征。结论低剂量5-氟尿嘧啶持续静脉滴注治疗常规含5-FU方案失败的进展期结直肠癌的近期疗效较好,毒副反应较低,值得进一步研究应用。 Objective To evaluate the efficacy and adverse effects of continuous venous Infusion(CIV)of low-dose 5-fluorouracil(5-FU)in the treatment of metastasis colorectal cancer.Methods 17 patients with metastasis colorectal cancer received the regimen of 5-FU 200 mg/(m2·d) continuous venous infusion until disease progression or intolerable adverse effect.Efficacy was evaluated after 30 days.Results No patient achieved complete response(CR),2 patients partial response(PR),7 patients stable disease(SD),8 patients progression disease(PD),response rate(RR) was 11.7%,clinical benefit rate(CR+PR+SD)was 52.8%.The major toxicity included I^II mucositis and hand-food syndrome.Conclusion This study shows that the regimen of continuous venous Infusion of low-dose 5-fluorouracil is effective and good tolerable in metastasis colorectal cancer.
出处 《中国实用医药》 2013年第4期16-17,共2页 China Practical Medicine
关键词 低剂量5-氟尿嘧啶 持续静脉滴注 进展期结直肠癌 Low-dose 5-fluorouracil Continuous venous infusion Metastasis colorectal cancer
  • 相关文献

参考文献7

  • 1Grothey A, Sargent D, Goldberg RM, et al. Survival of patients with advanced colorectal cancer improves with the availability of flu- orouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol, 2004, 22(7) :1209-14. 被引量:1
  • 2Jain RK. Normalization of tumor vaseulature : An emerging concept in antiangiogenic therapy. Science, 2005, 307 (5706) :58-62. 被引量:1
  • 3Cunningham D, Humblet Y, Siena S,et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med, 2004, 351(4) :337-45. 被引量:1
  • 4Hanahan D, Bergers G, Bergsland E. Less is more, regularly: met- ronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest, 2000,105(8) :1045-7. 被引量:1
  • 5Colleoni M, Rocca A, Sandri MT, et al. Low-dose oral methotrex- ate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor lev- els. Ann Oncol, 2002,13 ( 1 ) :73-80. 被引量:1
  • 6GhiringheUi F, Menard C, Puig PE, et al. Metronomic cyclophos- phamide regimen selectively depletes CIM + CD25 + regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunot Immunother, 2007,56(5 ) :641-8. 被引量:1
  • 7Ooyama A, Oka T, Zhao H, et al. Anti-angiogenic effect of 5-Flu- orouracil-based drugs against human colon cancer xenogrufts. Canc- er Lett, 2008,267( 1 ) :26-36. 被引量:1

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部